Compared with poor response, good response to obesity treatment was associated with lower risk of type 2 diabetes (adjusted ...

Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the ...

New recommendations on how to define obesity would reduce the emphasis on body mass index and also take into account health ...

Scheduled for 13 weeks, the trial will assess the therapy’s safety, tolerability, and efficacy in weight loss.